+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Japan Proton Therapy Market, Patients by 10 Cancer Types(CNS, Head and Neck, Lung, GI, HCC, Pancreas, Gynecologic, Prostate, etc.), Reimbursement Policies & Persons Treated at Centers

  • ID: 4833262
  • Report
  • Region: Japan
  • 105 Pages
  • Renub Research
1 of 4
The Japan Proton Therapy Market Potential is Expected to Cross US$ 6 Billion by the End of the Year 2025

FEATURED COMPANIES

  • Elekta
  • IBA
  • Varian Medical Systems
  • MORE

In Japan, the University of Tsukuba started clinical research and development in the year 1983. This was the first university in Japan that facilitates research and development of proton therapy and it created various milestones at various levels like started treatment of multiple cancerous tumors and creating a worldwide standard of proton therapy etc. In Japan, the number of patients eligibility for proton therapy is much higher than the proton therapy center, which treated the patients. According to our research, Japan is the largest proton therapy hub in Asia. The Japan Proton Therapy Market potential is expected to cross US$ 6 Billion by the end of the year 2025.

Rising cancer prevalence, increasing aging population, growing per capita expenditure, increasing number of proton therapy center in Japan will further boost the proton therapy market in the future course of time. In the early time, proton therapy was used to treat specific kind of cancers like prostate, CNS, etc. but now proton therapy technology can treat various cancer at every stage of life; from pediatric to adult and old age also.

Patients Insight - Japan Proton Therapy

This report contains full information about patients, who are likely to get treated with proton therapy, the actual number of patients who have received proton therapy treatment. Moreover we have also categorized the patients on the basis of disease or cancer type into 10 parts; Head and Neck Cancer, Central Nervous System (CNS) Tumors, GI (Gastro-Intestinal) Cancer, Hepatocellular Carcinoma (HCC), Pancreas Cancer, Prostate Cancer, Lung Cancer, Gynecologic Cancers, Bone and Soft Tissue Cancer, Others). We have also provided an in-depth analysis of the proton therapy center in Japan, providing a treated patient number by each year and by each operational center in Japan.

Market Insight - Japan Proton Therapy

Japan is one of the largest hubs of proton therapy center in the Asian region. The rising technological development and increasing cutting-edge technology in radiotherapy in Japan will further propel the proton therapy market of Japan in the forecast period. The rising new under-contraction proton therapy center in Japan due to cancer patient in Japan is increasing at a rapid pace, and it will continue in the future course of time.

This report on Japan Proton Therapy Market, Patients by 10 Cancer Types (Central Nervous System (CNS), Head and Neck, Lung, GI (Gastro-Intestinal), Hepatocellular Carcinoma (HCC), Pancreas, Gynecologic, Prostate, Bone and Soft Tissue, Others) Reimbursement Policies & Persons Treated at Centers provides a comprehensive assessment of the fast-evolving, high-growth of Japan Proton Therapy Market.

The report studies the market and patients numbers, of 10 individual cancer types who are treated under proton therapy. The report also talks about the list of all operational and future Proton Therapy centers; Reimbursement Policies. The report also studies the Proton Therapy Revenue of 3 Companies.

Types of Proton Therapy Market (Actual & Untapped)

1. Actual Market is the current market which is already present.
2. Untapped Market is the market which can be achieved, but it has yet not been achieved due to the demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year.

Japan Proton Therapy Market has been analyzed from six viewpoints

1. Actual Market
2. Potential Market
3. Treated Patient Numbers
4. Untapped Patient Numbers
5. Cancer Type - Japan Proton Therapy Market
6. Cancer Type - Japan Proton Therapy Number of Patients

10 Types of Cancer Patient Numbers and Market in Japan Proton Therapy

1. Central Nervous System (CNS) Tumors
2. Head and Neck Cancer
3. Prostate Cancer
4. Lung Cancer
5. GI (Gastro-Intestinal) Cancer
6. Hepatocellular Carcinoma (HCC) Cancer
7. Pancreas Cancer
8. Gynecologic Cancers
9. Bone and Soft Tissue Cancer
10. Others Cancer

Key Companies Covered

1. IBA (Overview, Sales Analysis)
2. Varian Medical Systems (Overview, Sales Analysis)
3. Elekta (Overview, Sales Analysis)

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Elekta
  • IBA
  • Varian Medical Systems
  • MORE

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market (Actual & Untapped) - Japan Proton Therapy (2009 - 2025)
4.1 Actual Proton Therapy Market
4.2 Untapped Proton Therapy Market

5. Number of Patients - Japan Proton Therapy (2009 - 2025)
5.1 Actual Numbers
5.2 Untapped Numbers

6. Cancer Types - Japan Proton Therapy Number of Patients (2009 - 2025)
6.1 Central Nervous System (CNS) Tumors
6.2 Head and Neck Cancer
6.3 Lung Cancer
6.4 GI (Gastro-Intestinal) Cancer
6.5 Hepatocellular Carcinoma (HCC) Cancer
6.6 Pancreas Cancer
6.7 Gynecologic Cancers
6.8 Prostate Cancer
6.9 Bone and Soft Tissue Cancer
6.10 Others Cancer

7. Cancer Types - Japan Proton Therapy Market (2009 - 2025)
7.1 Central Nervous System (CNS) Tumors
7.2 Head and Neck Cancer
7.3 Lung Cancer
7.4 GI (Gastro-Intestinal) Cancer
7.5 Hepatocellular Carcinoma (HCC) Cancer
7.6 Pancreas Cancer
7.7 Gynecologic Cancers
7.8 Prostate Cancer
7.9 Bone and Soft Tissue Cancer
7.10 Others Cancer

8. Japan - List of Proton Therapy Centers
8.1 Operating Proton Therapy Centers
8.2 Under-Construction Therapy Centers

9. By Centers - Number of Proton Therapy Patients Treated
9.1 Kashiwa (NCC) Proton Therapy Center (2008 - 2016)
9.2 Hyogo (HIBMC) Proton Therapy Center (2008 - 2016)
9.3 Tsukuba (PMRC, 2) Proton Therapy Center (2008 - 2016)
9.4 WERC Proton Therapy Center (2008 - 2009)
9.5 Shizuoka Proton Therapy Center (2008 - 2016)
9.6 Koriyama-City Proton Therapy Center (2008 - 2016)
9.7 Ibusuki (MMRI) Proton Therapy Center (2011 - 2016)
9.8 Fukui City (Prefectural Hospital) Proton Therapy Center (2013 - 2015)
9.9 Nagoya PTC, Nagoya, Aichi Proton Therapy Center (2013 - 2016)
9.10 Tosu (Saga-HIMAT) Proton Therapy Center (2013)
9.11 Nagano Proton Therapy Center (2014 - 2016)
9.12 Hokkaido Proton Therapy Center (2014 - 2016)

10. Reimbursement Policies - Japan Proton Therapy

11. Components of a Standard Proton Therapy Center
11.1 Type of Proton Accelerator
11.1.1 Synchrotrons (example: LLUMC at Loma Linda)
11.1.2 Cyclotrons (example: MGH Boston)
11.1.3 Synchrocyclotrons (examples: Orsay, Uppsala)
11.1.4 Linacs (Rome)
11.1.5 H-minus Synchrotrons
11.1.6 Separated Sector Cyclotrons
11.1.7 Superconducting Cyclotrons
11.1.8 Fast Cycling Synchrotron
11.2 Beam Transport System
11.3 Beam Delivery System
11.3.1 The Passive Scattering Technique
11.3.2 Beam Scanning
11.4 Type of Nozzle
11.4.1 Single Scattering
11.4.2 Double Scattering
11.4.3 Uniform Scanning Nozzle
11.4.4 Pencil Scanning Nozzle
11.5 Treatment Planning System
11.6 Image Viewers
11.7 Patient Positioning System (PPS)
11.8 Human Resource

12. Company Analysis (2014 - 2025)
12.1 IBA Proton Therapy
12.1.1 Sales Analysis
12.2 Varian Medical Systems
12.2.1 Sales Analysis
12.3 Elekta
12.3.1 Sales Analysis

13. Proton Therapy - Driving Factors
13.1 Technology Advancement
13.1.1 Next-Generation Proton Technique
13.2 Growing Incidence of Cancer Patients in Japan

14. Challenges
14.1 Requires Huge Investment
14.2 Operation Challenges

List of Figures
Figure 2-1: Japan - Proton Therapy Market (Million US$), 2009 - 2018
Figure 2-2: Japan - Forecast for Proton Therapy Market (Million US$), 2019 - 2025
Figure 2-3: Japan - Untapped Proton Therapy Market (Million US$), 2009 - 2018
Figure 2-4: Japan - Forecast for Untapped Proton Therapy Market (Million US$), 2019 - 2025
Figure 3-1: Japan - Patient Treated with Proton Therapy (Number), 2009 - 2018
Figure 3-2: Japan - Forecast for Patient Treated with Proton Therapy (Number), 2019 - 2025
Figure 3-3: Japan - Untapped Patients for Proton Therapy (Number), 2009 - 2018
Figure 3-4: Japan - Forecast for Untapped Patients for Proton Therapy (Number), 2019 - 2025
Figure 4-1: Japan - Proton Therapy Patients by CNS (Number), 2009 - 2018
Figure 4-2: Japan - Forecast for Proton Therapy Patients by CNS (Number), 2019 - 2025
Figure 4-3: Japan - Proton Therapy Patients by Head and Neck (Number), 2009 - 2018
Figure 4-4: Japan - Forecast for Proton Therapy Patients by Head and Neck (Number), 2019 - 2025
Figure 4-5: Japan - Proton Therapy Patients by Lung Cancer (Number), 2009 - 2018
Figure 4-6: Japan - Forecast for Proton Therapy Patients by Lung Cancer (Number), 2019 - 2025
Figure 4-7: Japan - Proton Therapy Patients by GI Cancer (Number), 2009 - 2018
Figure 4-8: Japan - Forecast for Proton Therapy Patients by GI Cancer (Number), 2019 - 2025
Figure 4-9: Japan - Proton Therapy Patients by HCC (Number), 2009 - 2018
Figure 4-10: Japan - Forecast for Proton Therapy Patients by HCC (Number), 2019 - 2025
Figure 4-11: Japan - Proton Therapy Patients by Pancreas (Number), 2009 - 2018
Figure 4-12: Japan - Forecast for Proton Therapy Patients by Pancreas (Number), 2019 - 2025
Figure 4-13: Japan - Proton Therapy Patients by Gynecologic Cancer (Number), 2009 - 2018
Figure 4-14: Japan - Forecast for Proton Therapy Patients by Gynecologic Cancer (Number), 2019 - 2025
Figure 4-15: Japan - Proton Therapy Patients by Prostate Cancer (Number), 2009 - 2018
Figure 4-16: Japan - Forecast for Proton Therapy Patients by Prostate Cancer (Number), 2019 - 2025
Figure 4-17: Japan - Proton Therapy Patients by Bone and Soft Tissue (Number), 2009 - 2018
Figure 4-18: Japan - Forecast for Proton Therapy Patients by Bone and Soft Tissue (Number), 2019 - 2025
Figure 4-19: Japan - Proton Therapy Patients by Others (Number), 2009 - 2018
Figure 4-20: Japan - Forecast for Proton Therapy Patients by Others (Number), 2019 - 2025
Figure 5-1: Japan - Proton Therapy Market by CNS (Million US$), 2009 - 2018
Figure 5-2: Japan - Forecast for Proton Therapy Market by CNS (Million US$), 2015 - 2025
Figure 5-3: Japan - Proton Therapy Market by Head and Neck Cancer (Million US$), 2009 - 2018
Figure 5-4: Japan - Forecast for Proton Therapy Market by Head and Neck Cancer (Million US$), 2019 - 2025
Figure 5-5: Japan - Proton Therapy Market by Lung Cancer (Million US$), 2009 - 2018
Figure 5-6: Japan - Forecast for Proton Therapy Market by Lung Cancer (Million US$), 2019 - 2025
Figure 5-7: Japan - Proton Therapy Market by GI Cancer (Million US$), 2009 - 2018
Figure 5-8: Japan - Forecast for Proton Therapy Market by GI Cancer (Million US$), 2019 - 2025
Figure 5-9: Japan - Proton Therapy Market by HCC (Million US$), 2009 - 2018
Figure 5-10: Japan - Forecast for Proton Therapy Market by HCC (Million US$), 2019 - 2025
Figure 5-11: Japan - Proton Therapy Market by Pancreas (Million US$), 2009 - 2018
Figure 5-12: Japan - Forecast for Proton Therapy Market by Pancreas (Million US$), 2019 - 2025
Figure 5-13: Japan - Proton Therapy Market by Gynecologic cancers (Million US$), 2009 - 2018
Figure 5-14: Japan - Forecast for Proton Therapy Market by Gynecologic cancers (Million US$), 2019 - 2025
Figure 5-15: Japan - Proton Therapy Market by Prostate cancers (Million US$), 2009 - 2018
Figure 5-16: Japan - Forecast for Proton Therapy Market by Prostate cancers (Million US$), 2019 - 2025
Figure 5-17: Japan - Proton Therapy Market by Bone and Soft Tissue (Million US$), 2009 - 2018
Figure 5-18: Japan - Forecast for Proton Therapy Market by Bone and Soft Tissue (Million US$), 2019 - 2025
Figure 5-19: Japan - Proton Therapy Market by Others (Million US$), 2009 - 2018
Figure 5-20: Japan - Forecast for Proton Therapy Market by Others (Million US$), 2019 - 2025
Figure 10-1: Global - IBA Proton Therapy Sales (Million USD), 2014 - 2018
Figure 10-2: Global - Forecast for IBA Proton Therapy Sales (Million USD), 2019 - 2025
Figure 10-3: Global - Varian Medical Systems Oncology Systems Sales (Million USD), 2014 - 2018
Figure 10-4: Global - Forecast for Varian Medical Systems Oncology Systems Sales (Million USD), 2019 - 2025
Figure 10-5: Global - Elekta Revenue, (Million USD), 2014 - 2018
Figure 10-6: Global - Forecast for Elekta Revenue (Million USD), 2019 - 2025
Figure 11-1: Japan - Number of Patients Diagnosed With Cancer (Thousand), 2014 - 2018
Figure 11-2: Japan - Forecast for Number of Patients Diagnosed With Cancer (Thousand), 2019 - 2025

List of Tables:
Table 6-1: Japan - Proton Therapy Centers in Operation
Table 6-2: Japan - Proton Therapy Centers in Under-Construction
Table 7-1: Japan - Kashiwa (NCC) Proton Therapy Center with Patients Treated (Number), 2008 - 2016
Table 7-2: Japan - Hyogo (HIBMC) Proton Therapy Center with Patients Treated (Number), 2008 - 2016
Table 7-3: Japan - Tsukuba (PMRC, 2) Proton Therapy Center with Patients Treated (Number), 2008 - 2016
Table 7-4: Japan - WERC Proton Therapy Center with Patients Treated (Number), 2008 - 2009
Table 7-5: Japan - Shizuoka Proton Therapy Center with Patients Treated (Number), 2008 - 2016
Table 7-6: Japan - Koriyama-City Proton Therapy Center with Patients Treated (Number), 2011 - 2016
Table 7-7: Japan - Ibusuki (MMRI) Proton Therapy Center with Patients Treated (Number), 2011 - 2016
Table 7-8: Japan - Fukui City (Prefectural Hospital) Proton Therapy Center with Patients Treated (Number), 2013 - 2015
Table 7-9: Japan - Nagoya PTC, Nagoya, Aichi Proton Therapy Center with Patients Treated (Number), 2013 - 2016
Table 7-10: Japan - Tosu (Saga-HIMAT) Proton Therapy Center with Patients Treated (Number), 2013
Table 7-11: Japan - Nagano Proton Therapy Center with Patients Treated (Number), 2014 - 2016

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Elekta
  • IBA
  • Varian Medical Systems
Note: Product cover images may vary from those shown
5 of 4

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...

Adroll
adroll